Literature DB >> 16327495

Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen.

Sourabh Ghosh1, Rachel Rosenthal, Paul Zajac, Walter P Weber, Daniel Oertli, Michael Heberer, Ivan Martin, Giulio C Spagnoli, Anca Reschner.   

Abstract

OBJECTIVE: To assess the effects of the culture of melanoma cells in 3-dimensional (3D) architectures on their immunorecognition by cytotoxic T lymphocytes (CTLs) specific for tumor-associated antigens. SUMMARY BACKGROUND DATA: Growth in 3D architectures has been shown to promote the resistance of cancers to treatment with drugs, cytokines, or irradiation, thereby potentially playing an important role in tumor expansion. We investigated the effects of 3D culture on the recognition of melanoma cells by antigen-specific HLA class I-restricted CTLs.
METHODS: Culture of HBL melanoma cells expressing Melan-A/Mart-1 tumor-associated antigen and HLA-A0201 on poly-2-hydroxyethyl methacrylate (polyHEMA)-coated plates resulted in the generation of aggregates of 400- to 500-microm diameters containing on average 30,000 cells and characterized by slower proliferation, as compared with monolayer (2-dimensional) cultures. HLA-A0201 restricted Melan-A/Mart-127-35-specific CTL clones were used to evaluate tumor cell immunorecognition measured as specific IFN-gamma production. Comparative gene and protein expression in 2D and 3D cultures was studied by real-time PCR and flow cytometry, respectively. Overall differences in gene expression profiles between 2D and 3D cultures were evaluated by high-density oligonucleotide array hybridization.
RESULTS: HLA-A0201 restricted Melan-A/Mart-127-35 specific CTL clones produced high amounts of IFN-gamma upon short-term (4-24 hours) coincubation with HBL cells cultured in 2D but not in 3D, thus suggesting altered antigen recognition. Indeed, Melan-A/Mart-1 expression, at both gene and protein levels, was significantly decreased in 3D as compared with 2D cultures. Concomitantly, a parallel decrease of HLA class I molecule expression was also observed. Differential gene profiling studies on HBL cells showed an increased expression of genes encoding molecules involved in intercellular adhesion, such as junctional adhesion molecule 2 and cadherin-like 1 (>20- and 8-fold up-regulated, respectively) in 3D as compared with 2D cultures.
CONCLUSIONS: Taken together, our data suggest that mere growth of melanoma cells in 3D architectures, in the absence of immunoselective pressure, may result in defective recognition by tumor-associated antigen-specific CTL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16327495      PMCID: PMC1409875          DOI: 10.1097/01.sla.0000189571.84213.b0

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  25 in total

Review 1.  HLA class I antigen abnormalities and immune escape by malignant cells.

Authors:  Barbara Seliger; Teresa Cabrera; Federico Garrido; Soldano Ferrone
Journal:  Semin Cancer Biol       Date:  2002-02       Impact factor: 15.707

2.  Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo.

Authors:  Daniel Oertli; Walter R Marti; Paul Zajac; Christoph Noppen; Thomas Kocher; Elisabetta Padovan; Michel Adamina; Reto Schumacher; Felix Harder; Michael Heberer; Giulio C Spagnoli
Journal:  Hum Gene Ther       Date:  2002-03-01       Impact factor: 5.695

Review 3.  A listing of human tumor antigens recognized by T cells.

Authors:  N Renkvist; C Castelli; P F Robbins; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  2001-03       Impact factor: 6.968

4.  A novel autocrine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down-modulation of its promoter.

Authors:  J T Kurnick; T Ramirez-Montagut; L A Boyle; D M Andrews; F Pandolfi; P J Durda; D Butera; I S Dunn; E M Benson; S J Gobin; P J van den Elsen
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction.

Authors:  A F Ochsenbein; S Sierro; B Odermatt; M Pericin; U Karrer; J Hermans; S Hemmi; H Hengartner; R M Zinkernagel
Journal:  Nature       Date:  2001-06-28       Impact factor: 49.962

6.  Impact of human bladder cancer cell architecture on autologous T-lymphocyte activation.

Authors:  Virginie Dangles; Pierre Validire; Mireille Wertheimer; Sophie Richon; Christophe Bovin; Dominique Zeliszewski; Guy Vallancien; Dominique Bellet
Journal:  Int J Cancer       Date:  2002-03-01       Impact factor: 7.396

7.  Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.

Authors:  M C Mihm; C G Clemente; N Cascinelli
Journal:  Lab Invest       Date:  1996-01       Impact factor: 5.662

8.  Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns.

Authors:  V Dangles; V Lazar; P Validire; S Richon; M Wertheimer; V Laville; J-L Janneau; M Barrois; C Bovin; T Poynard; G Vallancien; D Bellet
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

9.  High density oligonucleotide array analysis of interferon- alpha2a sensitivity and transcriptional response in melanoma cells.

Authors:  U Certa; M Seiler; E Padovan; G C Spagnoli
Journal:  Br J Cancer       Date:  2001-07-06       Impact factor: 7.640

10.  Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters.

Authors:  Jörn Gotter; Benedikt Brors; Manfred Hergenhahn; Bruno Kyewski
Journal:  J Exp Med       Date:  2004-01-19       Impact factor: 14.307

View more
  13 in total

1.  The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.

Authors:  Lixin Wan; Ming Chen; Juxiang Cao; Xiangpeng Dai; Qing Yin; Jinfang Zhang; Su-Jung Song; Ying Lu; Jing Liu; Hiroyuki Inuzuka; Jesse M Katon; Kelsey Berry; Jacqueline Fung; Christopher Ng; Pengda Liu; Min Sup Song; Lian Xue; Roderick T Bronson; Marc W Kirschner; Rutao Cui; Pier Paolo Pandolfi; Wenyi Wei
Journal:  Cancer Discov       Date:  2017-02-07       Impact factor: 39.397

Review 2.  Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics.

Authors:  Jennifer H Hammel; Jonathan M Zatorski; Sophie R Cook; Rebecca R Pompano; Jennifer M Munson
Journal:  Adv Drug Deliv Rev       Date:  2022-01-11       Impact factor: 15.470

Review 3.  Research Progress on the Immunogenicity and Regeneration of Acellular Adipose Matrix: A Mini Review.

Authors:  Kaiyang Liu; Yunfan He; Feng Lu
Journal:  Front Bioeng Biotechnol       Date:  2022-06-06

4.  A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant.

Authors:  Michael J Giffin; Holly Heaslet; Ashraf Brik; Ying-Chuan Lin; Gabrielle Cauvi; Chi-Huey Wong; Duncan E McRee; John H Elder; C David Stout; Bruce E Torbett
Journal:  J Med Chem       Date:  2008-09-30       Impact factor: 7.446

5.  Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells?

Authors:  Antonia Busse; Anne Letsch; Alberto Fusi; Anika Nonnenmacher; David Stather; Sebastian Ochsenreither; Christian R A Regenbrecht; Ulrich Keilholz
Journal:  Clin Exp Metastasis       Date:  2013-03-22       Impact factor: 5.150

6.  3D porous chitosan-alginate scaffolds: a new matrix for studying prostate cancer cell-lymphocyte interactions in vitro.

Authors:  Stephen J Florczyk; Gang Liu; Forrest M Kievit; Allison M Lewis; Jennifer D Wu; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2012-07-06       Impact factor: 9.933

7.  A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents.

Authors:  Sylvia Herter; Laura Morra; Ramona Schlenker; Jitka Sulcova; Linda Fahrni; Inja Waldhauer; Steffi Lehmann; Timo Reisländer; Irina Agarkova; Jens M Kelm; Christian Klein; Pablo Umana; Marina Bacac
Journal:  Cancer Immunol Immunother       Date:  2016-11-17       Impact factor: 6.968

8.  Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes.

Authors:  C Feder-Mengus; S Ghosh; W P Weber; S Wyler; P Zajac; L Terracciano; D Oertli; M Heberer; I Martin; G C Spagnoli; A Reschner
Journal:  Br J Cancer       Date:  2007-03-06       Impact factor: 7.640

Review 9.  Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy.

Authors:  Raquel Tarazona; Esther Duran; Rafael Solana
Journal:  Front Immunol       Date:  2016-01-07       Impact factor: 7.561

10.  Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment.

Authors:  Silvio Däster; Nunzia Amatruda; Diego Calabrese; Robert Ivanek; Eleonora Turrini; Raoul A Droeser; Paul Zajac; Carmela Fimognari; Giulio C Spagnoli; Giandomenica Iezzi; Valentina Mele; Manuele G Muraro
Journal:  Oncotarget       Date:  2017-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.